182 related articles for article (PubMed ID: 18783468)
1. New insights into intra- and intermolecular interactions of immunoglobulins: crystal structure of mouse IgG2b-Fc at 2.1-A resolution.
Kolenko P; Dohnálek J; Dusková J; Skálová T; Collard R; Hasek J
Immunology; 2009 Mar; 126(3):378-85. PubMed ID: 18783468
[TBL] [Abstract][Full Text] [Related]
2. Structure of the murine unglycosylated IgG1 Fc fragment.
Feige MJ; Nath S; Catharino SR; Weinfurtner D; Steinbacher S; Buchner J
J Mol Biol; 2009 Aug; 391(3):599-608. PubMed ID: 19559712
[TBL] [Abstract][Full Text] [Related]
3. Refined structure of an intact IgG2a monoclonal antibody.
Harris LJ; Larson SB; Hasel KW; McPherson A
Biochemistry; 1997 Feb; 36(7):1581-97. PubMed ID: 9048542
[TBL] [Abstract][Full Text] [Related]
4. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types.
Kanda Y; Yamada T; Mori K; Okazaki A; Inoue M; Kitajima-Miyama K; Kuni-Kamochi R; Nakano R; Yano K; Kakita S; Shitara K; Satoh M
Glycobiology; 2007 Jan; 17(1):104-18. PubMed ID: 17012310
[TBL] [Abstract][Full Text] [Related]
5. The crystal structure of an avian IgY-Fc fragment reveals conservation with both mammalian IgG and IgE.
Taylor AI; Fabiane SM; Sutton BJ; Calvert RA
Biochemistry; 2009 Jan; 48(3):558-62. PubMed ID: 19115948
[TBL] [Abstract][Full Text] [Related]
6. Crystallization and preliminary X-ray analysis of the monoclonal anti-tumor antibody BR96 and its complex with the Lewis Y determinant.
Chang CY; Jeffrey PD; Bajorath J; Hellström I; Hellström KE; Sheriff S
J Mol Biol; 1994 Jan; 235(1):372-6. PubMed ID: 8289260
[TBL] [Abstract][Full Text] [Related]
7. Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity.
Krapp S; Mimura Y; Jefferis R; Huber R; Sondermann P
J Mol Biol; 2003 Jan; 325(5):979-89. PubMed ID: 12527303
[TBL] [Abstract][Full Text] [Related]
8. Structural comparison of fucosylated and nonfucosylated Fc fragments of human immunoglobulin G1.
Matsumiya S; Yamaguchi Y; Saito J; Nagano M; Sasakawa H; Otaki S; Satoh M; Shitara K; Kato K
J Mol Biol; 2007 May; 368(3):767-79. PubMed ID: 17368483
[TBL] [Abstract][Full Text] [Related]
9. The crystal structure of rabbit IgG-Fc.
Girardi E; Holdom MD; Davies AM; Sutton BJ; Beavil AJ
Biochem J; 2009 Jan; 417(1):77-83. PubMed ID: 18764781
[TBL] [Abstract][Full Text] [Related]
10. Pairing of oligosaccharides in the Fc region of immunoglobulin G.
Masuda K; Yamaguchi Y; Kato K; Takahashi N; Shimada I; Arata Y
FEBS Lett; 2000 May; 473(3):349-57. PubMed ID: 10818239
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of deglycosylated human IgG4-Fc.
Davies AM; Jefferis R; Sutton BJ
Mol Immunol; 2014 Nov; 62(1):46-53. PubMed ID: 24956411
[TBL] [Abstract][Full Text] [Related]
12. Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose.
Ferrara C; Grau S; Jäger C; Sondermann P; Brünker P; Waldhauer I; Hennig M; Ruf A; Rufer AC; Stihle M; Umaña P; Benz J
Proc Natl Acad Sci U S A; 2011 Aug; 108(31):12669-74. PubMed ID: 21768335
[TBL] [Abstract][Full Text] [Related]
13. Crystal structures of immunoglobulin Fc heterodimers reveal the molecular basis for heterodimer formation.
Choi HJ; Seok SH; Kim YJ; Seo MD; Kim YS
Mol Immunol; 2015 Jun; 65(2):377-83. PubMed ID: 25743157
[TBL] [Abstract][Full Text] [Related]
14. Engineering the Fab fragment of the anti-IgE omalizumab to prevent Fab crystallization and permit IgE-Fc complex crystallization.
Mitropoulou AN; Ceska T; Heads JT; Beavil AJ; Henry AJ; McDonnell JM; Sutton BJ; Davies AM
Acta Crystallogr F Struct Biol Commun; 2020 Mar; 76(Pt 3):116-129. PubMed ID: 32133997
[TBL] [Abstract][Full Text] [Related]
15. Oligosaccharide-protein interactions in IgG can modulate recognition by Fc gamma receptors.
Lund J; Takahashi N; Pound JD; Goodall M; Nakagawa H; Jefferis R
FASEB J; 1995 Jan; 9(1):115-9. PubMed ID: 7821750
[TBL] [Abstract][Full Text] [Related]
16. The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling.
Boehm MK; Woof JM; Kerr MA; Perkins SJ
J Mol Biol; 1999 Mar; 286(5):1421-47. PubMed ID: 10064707
[TBL] [Abstract][Full Text] [Related]
17. Effect of posttranslational modifications on the thermal stability of a recombinant monoclonal antibody.
Liu H; Bulseco GG; Sun J
Immunol Lett; 2006 Aug; 106(2):144-53. PubMed ID: 16831470
[TBL] [Abstract][Full Text] [Related]
18. Structural differences between glycosylated, disulfide-linked heterodimeric Knob-into-Hole Fc fragment and its homodimeric Knob-Knob and Hole-Hole side products.
Kuglstatter A; Stihle M; Neumann C; Müller C; Schaefer W; Klein C; Benz J;
Protein Eng Des Sel; 2017 Sep; 30(9):649-656. PubMed ID: 28985438
[TBL] [Abstract][Full Text] [Related]
19. Impact of IgG Fc-Oligosaccharides on Recombinant Monoclonal Antibody Structure, Stability, Safety, and Efficacy.
Liu H; Nowak C; Andrien B; Shao M; Ponniah G; Neill A
Biotechnol Prog; 2017 Sep; 33(5):1173-1181. PubMed ID: 28547754
[TBL] [Abstract][Full Text] [Related]
20. An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations.
Vafa O; Gilliland GL; Brezski RJ; Strake B; Wilkinson T; Lacy ER; Scallon B; Teplyakov A; Malia TJ; Strohl WR
Methods; 2014 Jan; 65(1):114-26. PubMed ID: 23872058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
